Exactly. Cognate took on a huge risk in fronting the cost to set NWBO up for commercialization. And now it's time to pay them.
I remember reading back in July or so of 2013 when Cognate accepted shares in lieu of payment for debt owed. At the time, I was just becoming familiar with DCVax and really knew very little about the company. I did not know anything about Cognate except that they manufactured the treatment. And at that time I thought that was such a bullish sign that their manufacturer was willing to take shares as payment.
And guess what? Nothing's changed. I still think that.